| Issue Date | Title | Author(s) |
| 2021-02-03 | Managing low‐risk febrile neutropenia in children in the time of COVID‐19: What matters to parents and clinicians | Haeusler, GM; De Abreu Lourenco, R; Bakos, C; O'Brien, T; Slavin, MA; Clark, JE; McMullan, B; Borland, ML; Babl, FE; Krishnasamy, M; Vanevski, M; Thursky, KA; Hall, L |
| 2021-10-04 | Long-term health-related quality of life in young childhood cancer survivors and their parents. | Fardell, JE; Wakefield, CE; De Abreu Lourenco, R; Signorelli, C; McCarthy, M; McLoone, J; Osborn, M; Gabriel, M; Anazodo, A; Alvaro, F; Lockwood, L; Walwyn, T; Skeen, J; Tillemans, R; Cohn, RJ; ANZCHOG Survivorship Group, |
| 2021-12 | Cost-effectiveness of a complex intervention in general practice to increase uptake of long-acting reversible contraceptives in Australia. | Lewandowska, M; De Abreu Lourenco, R; Haas, M; Watson, CJ; Black, KI; Taft, A; Lucke, J; McGeechan, K; McNamee, K; Peipert, JF; Mazza, D |
| 2021-08-29 | Single-Fraction vs Multifraction Stereotactic Ablative Body Radiotherapy for Pulmonary Oligometastases (SAFRON II) | Siva, S; Bressel, M; Mai, T; Le, H; Vinod, S; de Silva, H; Macdonald, S; Skala, M; Hardcastle, N; Rezo, A; Pryor, D; Gill, S; Higgs, B; Wagenfuehr, K; Montgomery, R; Awad, R; Chesson, B; Eade, T; Wong, W; Sasso, G; De Abreu Lourenco, R; Kron, T; Ball, D; Neeson, P; Bettington, C; Cook, O; Foote, M; Gowda, R; Haas, M; Haynes, NM; Hilder, B; Lao, L; Lim, A; Ludbrook, J; Jansen, T; MacManus, M; McCullough, SA; Moore, A; Ritchie, D; Shaw, M; Sia, J; Syed, F; Tang, C; Trapani, J |
| 2021-01-01 | Diagnostic Yield of Initial and Consecutive Blood Cultures in Children With Cancer and Febrile Neutropenia | Haeusler, GM; De Abreu Lourenco, R; Clark, H; Thursky, KA; Slavin, MA; Babl, FE; Mechinaud, F; Alvaro, F; Clark, J; Padhye, B; Phillips, M; Super, L; Tapp, H; Walwyn, T; Ziegler, D; Phillips, R; Worth, LJ |
| 2022-09 | TROG 14.04: Multicentre Study of Feasibility and Impact on Anxiety of DIBH in Breast Cancer Patients. | Kron, T; Bressel, M; Lonski, P; Hill, C; Mercieca-Bebber, R; Ahern, V; Lehman, M; Johnson, C; Latty, D; Ward, R; Miller, D; Banjade, D; Morriss, D; De Abreu Lourenco, R; Woodcock, J; Montgomery, R; Lehmann, J; Chua, BH |
| 2022-10 | Preferences for a polygenic test to estimate cancer risk in a general Australian population. | Venning, B; Saya, S; De Abreu Lourenco, R; Street, DJ; Emery, JD |
| 2022-10-21 | Cost-effectiveness Analysis of Tisagenlecleucel Versus Blinatumomab in Children and Young Adults with Acute Lymphoblastic Leukemia: Partitioned Survival Model to Assess the Impact of an Outcome-Based Payment Arrangement. | Gye, A; Goodall, S; De Abreu Lourenco, R |
| 2022-04-19 | Surveillance Improves Outcomes for Carriers of SDHB Pathogenic Variants: A Multicenter Study. | Davidoff, DF; Benn, DE; Field, M; Crook, A; Robinson, BG; Tucker, K; De Abreu Lourenco, R; Burgess, JR; Clifton-Bligh, RJ |
| 2023-08-04 | [18F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial. | Koh, E-S; Gan, HK; Senko, C; Francis, RJ; Ebert, M; Lee, ST; Lau, E; Khasraw, M; Nowak, AK; Bailey, DL; Moffat, BA; Fitt, G; Hicks, RJ; Coffey, R; Verhaak, R; Walsh, KM; Barnes, EH; De Abreu Lourenco, R; Rosenthal, M; Adda, L; Foroudi, F; Lasocki, A; Moore, A; Thomas, PA; Roach, P; Back, M; Leonard, R; Scott, AM |
